Aurora Cannabis Inc (NASDAQ: ACB)’s stock price has gone decline by -2.81 in comparison to its previous close of 6.04, however, the company has experienced a -8.57% decrease in its stock price over the last five trading days. prnewswire.com reported 2025-02-14 that NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB, Feb. 14, 2025 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis products under the Company’s IndiMed brand. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products, providing greater patient access to high quality medical cannabis options.
Is It Worth Investing in Aurora Cannabis Inc (NASDAQ: ACB) Right Now?
Aurora Cannabis Inc (NASDAQ: ACB) has a higher price-to-earnings ratio of 37.25x compared to its average ratio. ACB has 36-month beta value of 1.79. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for ACB is 54.66M, and currently, short sellers hold a 9.32% ratio of that float. The average trading volume of ACB on February 19, 2025 was 2.65M shares.
ACB’s Market Performance
The stock of Aurora Cannabis Inc (ACB) has seen a -8.57% decrease in the past week, with a 52.47% rise in the past month, and a 35.25% gain in the past quarter. The volatility ratio for the week is 7.17%, and the volatility levels for the past 30 days are at 7.95% for ACB. The simple moving average for the past 20 days is 18.31% for ACB’s stock, with a 7.69% simple moving average for the past 200 days.
ACB Trading at 28.94% from the 50-Day Moving Average
After a stumble in the market that brought ACB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.22% of loss for the given period.
Volatility was left at 7.95%, however, over the last 30 days, the volatility rate increased by 7.17%, as shares surge +51.54% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +35.86% upper at present.
During the last 5 trading sessions, ACB fell by -7.94%, which changed the moving average for the period of 200-days by -19.70% in comparison to the 20-day moving average, which settled at $4.96. In addition, Aurora Cannabis Inc saw 38.12% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ACB
Current profitability levels for the company are sitting at:
- -0.16 for the present operating margin
- 0.54 for the gross margin
The net margin for Aurora Cannabis Inc stands at -0.23. The total capital return value is set at -0.04. Equity return is now at value 4.78, with 3.09 for asset returns.
Based on Aurora Cannabis Inc (ACB), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -0.55. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is -3.59.
Currently, EBITDA for the company is 20.47 million with net debt to EBITDA at -0.41. When we switch over and look at the enterprise to sales, we see a ratio of 2.31. The receivables turnover for the company is 4.3for trailing twelve months and the total asset turnover is 0.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.30.
Conclusion
To put it simply, Aurora Cannabis Inc (ACB) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
